Safe

Safe Equity Turnover

The Equity Turnover of Safe (ALSAF.PA) as of Nov 17, 2026 is -0.51. In the previous year, Equity Turnover was -0.60 — a change of -15.52% (higher).

Equity Turnover

-0.51

YoY

-15.52%

Last updated:

Equity Turnover of Safe is 2025 -0.51 . Equity Turnover of Safe was 2024 -0.60 . It decreases by -15.52% higher compared to the previous year.

The Safe Equity Turnover history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity Turnover
Date
Equity Turnover
Jan 1, 2018
0.00 EUR
Jan 1, 2019
-1.10 EUR
Jan 1, 2020
15.43 EUR
Jan 1, 2021
11.44 EUR
Jan 1, 2022
-4.58 EUR
Jan 1, 2023
-0.03 EUR
Jan 1, 2024
-0.60 EUR
Jan 1, 2025
-0.51 EUR
The Safe Equity Turnover history
YEAREquity TurnoverYoY
-0.51-15.52%
-0.60+1,984.68%
-0.03-99.37%
-4.58-140.05%
11.44-25.87%
15.43-1,506.16%
-1.10-37,858.08%
0.00-1.20%
0.00-54.34%
0.01+1,213.59%
0.00-41.17%
0.00—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Safe Stock analysis

What does Safe do? Safe SA generates revenue through the development, production, and commercialization of spinal surgery products. The company offers SteriSpine PS, a Pedicle Screw System, and SteriSpine LC, a Lumbar Cage System, both designed for safe implant positioning and surgical access. These products feature quick change handles, dual trials, and impact removal mechanisms, utilizing polyarylamid material reinforced with 50% glass fibers. The primary buyers are healthcare providers and hospitals specializing in orthopaedic surgery, focusing on minimally invasive spinal procedures. The firm's product portfolio targets spinal surgery segments requiring precise implant placement and efficient surgical workflows. SteriSpine PS and SteriSpine LC are marketed to medical professionals seeking reliable solutions for spinal stabilization. The company's focus on polyarylamid-based materials ensures durability and compatibility with surgical requirements. Sales are driven by the demand for advanced spinal surgery tools that enhance procedural safety and reduce operation times. Safe SA's commercial strategy emphasizes direct sales to orthopaedic departments and surgical centers. The company's products are positioned as premium solutions within the spinal surgery market, catering to institutions prioritizing patient safety and surgical precision. By concentrating on a limited range of high-demand products, Safe SA maintains a focused approach to market penetration and customer satisfaction. Safe is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Safe stock

Equity Turnover of Safe is -0.51 in 2025.

Equity Turnover of Safe changed from -0.60 to -0.51, representing a -15.52% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Equity Turnover Safe since 2006 – with annual values, charts, and detailed analysis.

Equity turnover measures how efficiently a company uses shareholders' equity to generate revenue. It is a component of the DuPont analysis framework.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Equity Turnover's Safe with sector peers and the industry average to assess whether it is attractive.

To evaluate Equity Turnover's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Equity Turnover.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Safe

All Key Metrics — Safe